Cargando…
How should we think about the unprecedented weight loss efficacy of incretin-mimetic drugs?
Autores principales: | Gou, Yang, Schwartz, Michael W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541183/ https://www.ncbi.nlm.nih.gov/pubmed/37781919 http://dx.doi.org/10.1172/JCI174597 |
Ejemplares similares
-
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets
por: Giommoni, Luca
Publicado: (2020) -
Undergraduate medical education; how far should we go?
por: Benamer, Hani TS
Publicado: (2007) -
Atherosclerotic renal artery stenosis: how should we do?
por: Jiang, Ying, et al.
Publicado: (2021) -
How should we fund end-of-life care in the US?
por: Arapakis, Karolos, et al.
Publicado: (2022) -
How Should We Think About the Role of the Brain in Glucose Homeostasis and Diabetes?
por: Deem, Jennifer D., et al.
Publicado: (2017)